CLX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Clorox Co (CLX) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company offers a stable dividend yield of 4% and has a strong brand presence, its recent financial performance shows declining revenue, net income, and EPS. Additionally, analysts' ratings remain neutral, and there are no significant positive trading signals or catalysts to suggest immediate upside potential. For now, holding the stock or exploring other opportunities may be more prudent.
The technical indicators suggest a mixed outlook. The MACD is above 0 and positively contracting, indicating mild bullish momentum. The RSI is neutral at 71.834, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading close to its resistance levels (R1: 127.957), which may limit immediate upside potential.
Clorox has declared a quarterly dividend of $1.24 per share, reflecting stable cash flow and a 4% dividend yield.
The company's focus on innovation and the recent GOJO acquisition could drive long-term growth in its B2B segment.
The consumer staples sector is considered a safe haven during economic downturns.
Financial performance in Q2 2026 shows a decline in revenue (-0.77% YoY), net income (-18.65% YoY), and EPS (-16.77% YoY).
Gross margin dropped to 42.86%, down 1.81% YoY, indicating cost pressures.
Analysts maintain neutral ratings with only modest price target increases, reflecting limited near-term growth expectations.
In Q2 2026, Clorox reported declining financial metrics: revenue dropped to $1.673 billion (-0.77% YoY), net income fell to $157 million (-18.65% YoY), and EPS decreased to $1.29 (-16.77% YoY). Gross margin also contracted to 42.86% (-1.81% YoY), highlighting cost pressures.
Analysts maintain a neutral stance on Clorox, with recent price target increases being modest. The highest target is $132, and the lowest is $112. Analysts cite challenges in organic sales trends and margin pressures but acknowledge potential benefits from the GOJO acquisition in the long term.
